✦ LIBER ✦

PCN30 THE ECONOMIC BENEFITS OFTEGAFURWITH URACIL (UFTORAL) IN FIRST- LINE METASTATIC COLORECTAL CANCER

✍ Scribed by SJ Ralston; J Almond

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical and economic benefits of ca

✍ Ward, S E; Kaltenthaler, E; Cowan, J; Marples, M; Orr, B; Seymour, M T 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

PCN84 Economic Evaluation of the Use of

✍ Lechuga, D.; Alva, M.; Leyva, V.; Salinas, G.E. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Reply: The clinical and economic benefit

✍ Ward, S E 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 39 KB

PCN11 Bevacizumab in Combination with Ch

✍ Ubago, R.; Castillo, M.A.; Flores, S.; Beltrán, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Economic impact of simplified de Gramont

✍ Samuel Limat; Claire-Hélène Bracco-Nolin; Christine Legat-Fagnoni; Loic Chaignea 📂 Article 📅 2006 🏛 Springer 🌐 French ⚖ 723 KB

PCN48 COST-MINIMIZATION ANALYSIS OF XELO

✍ R Caponero; MG Saggia; VD Nasciben; EA Santos; S Stefani 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB